Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients

Transplantation. 2017 Dec;101(12):e349. doi: 10.1097/TP.0000000000001926.

Authors

George Cholankeril¹, Andrew A Li¹, Eric R Yoo¹, Aijaz Ahmed¹

Affiliation

¹ Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA.

PMID: 28846556
DOI: 10.1097/TP.0000000000001926

No abstract available

MeSH terms

Antiviral Agents / adverse effects
Antiviral Agents / therapeutic use*
Graft Survival / drug effects*
Hepatitis C / diagnosis
Hepatitis C / drug therapy*
Hepatitis C / mortality
Hepatitis C / virology
Humans
Liver Transplantation* / adverse effects
Liver Transplantation* / mortality
Postoperative Complications / mortality
Postoperative Complications / prevention & control*
Postoperative Complications / virology
Recurrence
Risk Factors
Time Factors
Treatment Outcome

Substances

Antiviral Agents